![Frank V. Booth](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Frank V. Booth
Nessuna posizione attualmente
Storia della carriera di Frank V. Booth
Precedenti posizioni note di Frank V. Booth
Società | Posizione | Inizio | Fine |
---|---|---|---|
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - | - |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Direttore Tecnico/Scientifico/R&S | - | - |
Formazione di Frank V. Booth
University of Oxford | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 4 |
Regno Unito | 2 |
Posizioni
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
ELI LILLY AND COMPANY | Health Technology |
Aziende private | 2 |
---|---|
Sangart, Inc.
![]() Sangart, Inc. Pharmaceuticals: MajorHealth Technology Sangart, Inc. developed blood transfusion solutions. It is a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen delivery. The company was founded in 1998 and was headquartered in San Diego, CA. | Health Technology |
Novo Nordisk, Inc.
![]() Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
- Borsa valori
- Insiders
- Frank V. Booth
- Esperienza